Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
Titel:
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
Auteur:
Terpos, Evangelos Heath, Deborah J. Rahemtulla, Amin Zervas, Kostas Chantry, Andrew Anagnostopoulos, Athanasios Pouli, Anastasia Katodritou, Eirini Verrou, Evgenia Vervessou, Elisavet-Christine Dimopoulos, Meletios-Athanassios Croucher, Peter I.